Loading...
XSHG600511
Market cap3.29bUSD
Jan 17, Last price  
31.92CNY
1D
0.35%
1Q
-2.68%
Jan 2017
6.05%
Name

China National Medicines Corporation Ltd

Chart & Performance

D1W1MN
XSHG:600511 chart
P/E
11.22
P/S
0.48
EPS
2.84
Div Yield, %
2.45%
Shrs. gr., 5y
-0.32%
Rev. gr., 5y
5.11%
Revenues
49.70b
+9.23%
1,801,012,0322,333,882,1072,807,039,7153,573,788,0104,385,472,4695,194,599,5355,918,037,6147,042,245,9418,591,632,46210,081,474,20611,538,342,52112,078,194,12413,386,417,45336,284,746,32838,739,827,10444,644,476,40440,378,608,10746,468,602,84445,498,583,76449,696,045,528
Net income
2.15b
+9.26%
35,032,05050,370,39684,611,244131,102,366193,825,940226,599,176310,019,181271,261,168335,815,809411,509,713482,653,724512,845,021547,606,9051,141,484,9491,404,095,4001,603,898,6861,382,688,4361,754,084,2181,964,057,5592,145,998,746
CFO
2.73b
+13.84%
49,176,86392,199,043121,497,89979,475,727217,095,150255,178,001318,212,8510185,868,315185,563,414218,943,203440,285,456591,250,4271,074,491,395981,654,0681,776,070,4911,301,671,1041,957,451,0322,395,123,4542,726,657,097
Dividend
Jun 13, 20240.854 CNY/sh

Profile

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
URL
http://www.cncm.com.cn/
IPO date
Nov 27, 2002
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
49,696,046
9.23%
45,498,584
-2.09%
Cost of revenue
46,369,571
42,753,416
Unusual Expense (Income)
NOPBT
3,326,475
2,745,167
NOPBT Margin
6.69%
6.03%
Operating Taxes
596,420
559,181
Tax Rate
17.93%
20.37%
NOPAT
2,730,055
2,185,987
Net income
2,145,999
9.26%
1,964,058
11.97%
Dividends
(590,021)
(528,152)
Dividend yield
2.73%
2.51%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
268,354
332,557
Long-term debt
410,151
365,144
Deferred revenue
747,137
46,353
Other long-term liabilities
46,496
747,586
Net debt
(12,154,310)
(9,821,563)
Cash flow
Cash from operating activities
2,726,657
2,395,123
CAPEX
(145,124)
Cash from investing activities
(137,084)
Cash from financing activities
(632,176)
FCF
3,380,922
2,740,749
Balance
Cash
10,925,539
8,896,165
Long term investments
1,907,277
1,623,099
Excess cash
10,348,013
8,244,335
Stockholders' equity
14,576,905
15,845,419
Invested Capital
8,452,203
8,688,819
ROIC
31.85%
25.04%
ROCE
17.67%
16.18%
EV
Common stock shares outstanding
754,503
754,503
Price
28.62
2.58%
27.90
-11.51%
Market cap
21,593,876
2.58%
21,050,634
-11.51%
EV
11,196,832
12,873,733
EBITDA
3,535,030
2,934,741
EV/EBITDA
3.17
4.39
Interest
44,840
26,877
Interest/NOPBT
1.35%
0.98%